BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1874062)

  • 1. [Clinical significance of the determination of cellular DNA content in gynecologic neoplasms].
    Li ZX
    Zhonghua Fu Chan Ke Za Zhi; 1991 May; 26(3):177-9. PubMed ID: 1874062
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.
    Hedley DW; Friedlander ML; Taylor IW
    Cytometry; 1985 Jul; 6(4):327-33. PubMed ID: 4017799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nuclear DNA assay in gynecologic malignant tumors and its clinical significance].
    Cheng X
    Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):353-5. PubMed ID: 1782848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA flow cytometry: a predictor of a high-risk group in cervical cancer.
    Anton M; Nenutil R; Rejthar A; Kopecny J; Ptackova B; Zaloudik J
    Cancer Detect Prev; 1997; 21(3):242-6. PubMed ID: 9167041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized image analysis and flow cytometric evaluation of ovarian borderline tumors: a study of 24 cases.
    Esposito MJ; Fuchs A
    Cytometry; 1994 Dec; 18(4):218-22. PubMed ID: 7895528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of DNA content in cervical intraepithelial neoplasia by cytologic and histologic flow cytometry.
    Lambert B; Barrette B; LePage Y
    Can J Surg; 1989 May; 32(3):204-6. PubMed ID: 2713775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA distribution and chromosome number in human cervical carcinoma.
    Jakobsen A; Nielsen KV; Rønne M
    Anal Quant Cytol; 1983 Mar; 5(1):13-8. PubMed ID: 6846964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA examinations in gynecological cancer and breast cancer].
    Tropé C; Kaern J; Pettersen EO; Iversen OE
    Tidsskr Nor Laegeforen; 1991 May; 111(13):1638-42. PubMed ID: 2063365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of DNA image cytometry in addition to flow cytometry for the study of patients with advanced ovarian cancer.
    Rodenburg CJ; Ploem-Zaaijer JJ; Cornelisse CJ; Mesker WE; Hermans J; Heintz PA; Ploem JS; Fleuren GJ
    Cancer Res; 1987 Aug; 47(15):3938-41. PubMed ID: 3607741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA content in cervical neoplasia and its relationship to prognosis.
    Dudzinski MR; Haskill SJ; Fowler WC; Currie JL; Walton LA
    Obstet Gynecol; 1987 Mar; 69(3 Pt 1):373-7. PubMed ID: 3822284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry in cervical adenocarcinoma. Correlating DNA content analysis with the clinical picture.
    Kaspar HG; Dinh TV; Hannigan EV
    J Reprod Med; 1997 Mar; 42(3):170-2. PubMed ID: 9109087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DNA content and cell cycle phase analysis in uterine sarcomas and its clinical significance].
    Tan X; Chen G
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):551-4. PubMed ID: 11360642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of DNA content and nuclear morphology in borderline ovarian tumors.
    Drescher CW; Flint A; Hopkins MP; Roberts JA
    Gynecol Oncol; 1993 Feb; 48(2):242-6. PubMed ID: 8428698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Flow cytometry in exfoliative cytology of malignant tumor].
    Zuo LF
    Zhonghua Zhong Liu Za Zhi; 1990 Jul; 12(4):274-7. PubMed ID: 2272262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic significance of cellular DNA content and AgNOR count in ovarian cystadenoma].
    Lu XL; Yi WM; Wang LF
    Ai Zheng; 2003 Jan; 22(1):62-5. PubMed ID: 12561439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric evaluation of early invasive cervical cancer.
    Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
    Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DNA multiparametric analysis by flow cytometry of cancer of the uterine cervix].
    Kornovski Ia; Balev S; Ivanova F
    Akush Ginekol (Sofiia); 2002; 42(1):32-5. PubMed ID: 11935698
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cervix uteri cancer: determination of DNA content by means of cytophotometry].
    Wistuba I; Roa I; Villaseca MA; Araya JC; Capurro I
    Rev Med Chil; 1993 Aug; 121(8):873-9. PubMed ID: 8296094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A quantitative study on nuclear DNA content and morphological parameters in ovarian cystadenocarcinoma].
    Liu C; Zhao Y; Sun X
    Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):738-40. PubMed ID: 8728920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.